411 reports of this reaction
1.8% of all BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE reports
#16 most reported adverse reaction
PRODUCT USE ISSUE is the #16 most commonly reported adverse reaction for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, manufactured by AstraZeneca Pharmaceuticals LP. There are 411 FDA adverse event reports linking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE to PRODUCT USE ISSUE. This represents approximately 1.8% of all 23,211 adverse event reports for this drug.
Patients taking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE who experience product use issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT USE ISSUE is a less commonly reported adverse event for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, but still significant enough to appear in the safety profile.
In addition to product use issue, the following adverse reactions have been reported for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE:
The following drugs have also been linked to product use issue in FDA adverse event reports:
PRODUCT USE ISSUE has been reported as an adverse event in 411 FDA reports for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT USE ISSUE accounts for approximately 1.8% of all adverse event reports for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, making it a notable side effect.
If you experience product use issue while taking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.